SEC62 and colorectal carcinoma: Mechanistically, Sec62 reinforces the metastatic potentials of CRC cell via triggering the MAPK/JNK signalling pathway, which enhances the expression of UCA1 by upregulating phospho‐ATF2 (p‐ATF2) level.